Results 81 to 90 of about 940,251 (149)
Abstract Background Lysosomal dysfunction is central to Parkinson's disease (PD) pathogenesis, with GBA1 representing the strongest established genetic risk factor. Numerous other genes involved in lysosomal sphingolipid, glycosphingolipid, and ceramide metabolism have been proposed as contributors to PD, highlighting the need for genetic analyses ...
Konstantin Senkevich +21 more
wiley +1 more source
Pharmacological Chaperones and Coenzyme Q10 Treatment Improves Mutant β-Glucocerebrosidase Activity and Mitochondrial Function in Neuronopathic Forms of Gaucher Disease [PDF]
Gaucher disease (GD) is caused by mutations in the GBA1 gene, which encodes lysosomal β-glucocerebrosidase. Homozygosity for the L444P mutation in GBA1 is associated with high risk of neurological manifestations which are not improved by enzyme ...
Oropesa Ávila, Manuel +7 more
core +1 more source
A Case of Adult Type 1 Gaucher Disease Complicated by Temporal Intestinal Hemorrhage
A 21-year-old man with a history of sudden rectal hemorrhage was referred to our hospital. Examination disclosed thrombocytopenia and hepatosplenomegaly. A liver biopsy specimen demonstrated Gaucher cells in Glisson's capsule.
Junitsu Ito +15 more
doaj +1 more source
Glycosylation and functionality of recombinant β-glucocerebrosidase from various production systems
Synopsis The glycosylation of recombinant β-glucocerebrosidase, and in particular the exposure of mannose residues, has been shown to be a key factor in the success of ERT (enzyme replacement therapy) for the treatment of GD (Gaucher disease ...
Salit Tzaban +7 more
core
A proportion of idiopathic Parkinson's disease patients (PDidiopathic ) with dementia show altered CSF profiles of amyloid β (Aβ) and Tau. PD patients with Glucocerebrosidase (GBA) mutations (PDGBA ) present with even more cognitive decline than seen in ...
Henrik Zetterberg +48 more
core +1 more source
The L444P mutation in the GBA1 gene which encodes β-glucocerebrosidase-1, is a major risk factor for developing Parkinson's disease (PD) and dementia with Lewy bodies (DLB).
Eva Rodríguez-Traver +8 more
doaj +1 more source
Glucosylsphingosine affects mitochondrial function in a neuronal cell model
Gaucher disease arises from mutations in glucocerebrosidase resulting in accumulation of glucosylceramide, which is deacylated to glucosylsphingosine.
Valeria Nikolaenko +6 more
doaj +1 more source
Genetic and clinical characteristics of Filipino patients with Gaucher disease
Gaucher disease (GD) is a lysosomal storage disorder caused by the deficiency of the β-glucocerebrosidase enzyme due to disease causing mutations in the GBA1 (glucosidase beta acid) gene, leading to the abnormal accumulation of the lipid glucocerebroside
Mary Anne D. Chiong +2 more
doaj +1 more source
Lysosomal beta-Glucocerebrosidase Activity Measured by Multiple Methods.
Glucocerebrosidase activity in healthy (GM14643) and two Gaucher I cell lines (GM10870,GM10874 containing the N370S mutation) was measured by staining with (4) and image analysis by flow cytometry as well as by using a standard 4-methylumbelliferyl β-D ...
Breanna Michelle Mohr (3168264) +6 more
core +1 more source
Molecular analysis and expression of the human glucocerebrosidase gene [PDF]
Gaucher disease is the most prevalent lysosomal lipid storage disease caused by deficient glucocerebrosidase activity. It is transmitted as an autosomal recessive trait.
Wei, Chao
core

